Why Bell Potter just upgraded this smashing ASX 200 stock

After rising over 100% in 12 months, Bell Potter believes there is more to come.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Monadelphous Group Ltd (ASX: MND) shares have been smashing the market over the past 12 months.

During this time, the ASX 200 stock has risen over 100% to currently trade at $29.72.

Despite this incredible rise, this diversified services company has just received an upgrade from analysts at Bell Potter.

Let's see what the broker is saying about this high-flying stock.

A man holding a cup of coffee puts his thumb up and smiles while at laptop.

Image source: Getty Images

What is the broker saying?

Bell Potter has been impressed with the company's performance in FY 2026. It highlights that Monadelphous has won significantly more contracts than it was expecting.

Commenting on recent developments, the broker said:

Since we last published in November 2025, MND has maintained its robust contract award momentum, securing work packages (EC and M&I) valued at ~$835m, taking FY26TD contract award value to ~$1,400m (compared with ~$1,550m in the pcp). Notable contract awards include: the ~$250m multidisciplinary construction work package for Rio Tinto's Brockman Syncline 1 iron ore development (awarded 22 December 2025); and the $300m 5-year maintenance services contract with Rio Tinto for its iron ore operations in the Pilbara region, WA (awarded 14 January 2026).

Given EC and M&I contract terms are generally greater than one year, we anticipate progressively larger annual contract awards over FY24 to FY26TD to imply a positive revenue growth trajectory over FY26-28. For context, MND was awarded contracts valued at ~$1,650m in FY23, $2,090m in FY24, $2,280m in FY25 and $1,405m in FY26TD (~$2,600m annualised).

ASX 200 stock upgraded

According to the note, in response to these contract wins, Bell Potter has lifted its earnings estimates through to FY 2028.

This has seen the broker upgrade its shares to a buy rating with an improved price target of $33.00 (from $24.00).

Based on its current share price of $29.72, this implies potential upside of 11% for investors over the next 12 months.

In addition, Bell Potter is expecting a dividend yield of approximately 3% in FY 2026 from the ASX 200 stock, which boosts the total potential return to 14%.

Commenting on its buy recommendation, the broker said:

MND's contract award streak has exceeded our expectation, reflecting a stronger development pipeline in the Mining and Energy sectors than we had anticipated. We believe MND has won more than its fair share of work, reinforcing the company's position as a market leader with robust blue chip customer relationships. Importantly, MND's current orderbook builds a strong foundation for earnings growth in the near-term that is not reflected in consensus expectations.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Buy, hold, sell: Clarity Pharmaceuticals, New Hope, and Orica shares

Brokers have been looking at these shares this week. Are they bullish?

Read more »

Coal miner holding a giant coal rock in his hand and making a circle with his other hand.
Broker Notes

What is this broker saying about New Hope Group shares?

Here's Bell Potter's guidance following earnings results.

Read more »

A young woman wearing a red and white striped t-shirt puts her hand to her chin and looks sideways as she wonders whether to buy ASX shares
Broker Notes

3 ASX 200 shares at 52-week lows: Buy, hold, or sell?

These ASX 200 shares have experienced significant falls over the past 12 months. Is there value here?

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Broker Notes

Buy, hold, sell: BHP, CSL, and Woodside shares

Let's see if analysts are bullish or bearish on these giants.

Read more »